Table 1. Correlation of TACC3 expression and clinical prognosis in KRIC with different clinical characteristics by Kaplan-Meier plotter.

Clinical characteristics	OS		RFS
	HR (95%CI)	logrank P	HR (95%CI)	logrank P
Gender
Female	2.31(1.4-3.8)	0.00073***	0	0.023*
Male	2.58(1.76-3.76)	3.7e-07***	2.95(0.9-9.73)	0.062
Race
White	2.45(1.79-3.37)	9.1e-09***	1.78(0.39-8.13)	0.45
black/African American	2.83(0.6-13.27)	0.17	0	0.34
Stage
1	2.01(1.11-3.65)	0.019*	4.21(0.59-30.06)	0.12
2	10.43(1.35-80.35)	0.0051**	-	-
3	0.75(0.42-1.33)	0.32	0.19(0.02-1.56)	0.086
4	2.41(1.31-4.45)	0.0037**	-	-
Grade
1	-	-	-	-
2	0.75(0.42-1.36)	0.35	-	-
3	2.29(1.44-3.65)	0.00033***	0.19(0.02-1.56)	0.086
4	1.82(0.91-3.63)	0.083	-	-
Mutation burden
High	1.83(1.06-3.19)	0.029*	0.35(0.04-2.91)	0.31
Low	5.41(2.41-12.14)	4.9e-06***	14.8(1.44-151.96)	0.0036**

- Values indicate the sample number too low for meaningful analysis.

* Values indicate p<0.05, ** values indicate p<0.01, *** values indicate p<0.001.